Increased IKKα expression in the basal layer of the epidermis of transgenic mice enhances the malignant potential of skin tumors

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Alameda, Josefa P ^a   Moreno Maldonado, Rodolfo ^a   Fernández Aceñero, M Jesús ^b   Navarro, Manuel ^a   Page, Angustias ^a   Jorcano, José L ^a   Bravo, Ana ^c   Ramírez, Ángel ^a   Casanova, M Llanos ^a  

^a CIEMAT   (Spain)

^b Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA6 INTEGRIN; CYCLIN D1; HEMAGGLUTININ; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MASPIN; PHORBOL 13 ACETATE 12 MYRISTATE; TRANSCRIPTION FACTOR RELA; CHUK PROTEIN, MOUSE; I KAPPA B KINASE; SERINE PROTEINASE INHIBITOR; SERPIN B5; SERPIN-B5; TUMOR MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; BREAST CARCINOMA; CANCER REGRESSION; CELL POLARITY; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; CYTOARCHITECTURE; DOWN REGULATION; EPIDERMIS; EPIDERMIS HYPERPLASIA; HAIR FOLLICLE; KERATINOCYTE; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PROSTATE CARCINOMA; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SKIN CARCINOGENESIS; SKIN TUMOR; ANIMAL; CATTLE; DRUG EFFECT; ENZYMOLOGY; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; RABBIT; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALIA; MURINAE; MUS; MUS MUSCULUS;

ANIMALS; CATTLE; CELL PROLIFERATION; EPIDERMIS; I-KAPPA B KINASE; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHA6; KERATINOCYTES; MICE; MICE, TRANSGENIC; NF-KAPPA B; RABBITS; SERPINS; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE; TUMOR MARKERS, BIOLOGICAL;

EID: 79959996678     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021984     Document Type: Article

References (63)

1. Ghosh S, Karin M, (2002) Missing pieces in the NF-kappaB puzzle. Cell 109: S81-S96.
2. Hayden MS, Ghosh S, (2004) Signaling to NF-kappaB. Genes Dev 18: 2195-2224.
3. Shih VF, Tsui R, Caldwell A, Hoffmann A, (2011) A single NFkappaB system for both canonical and non-canonical signaling. Cell Res 21: 86-102.
4. Liu B, Park E, Zhu F, Bustos T, Liu, J, et al. (2006) A critical role for I kappaB kinase alpha in the development of human and mouse squamous cell carcinomas. Proc Natl Acad Sci U S A 103: 17202-17207.
5. Moreno-Maldonado R, Ramirez A, Navarro M, Fernandez-Acenero MJ, Villanueva C, et al. (2008) IKKalpha enhances human keratinocyte differentiation and determines the histological variant of epidermal squamous cell carcinomas. Cell Cycle 7: 2021-2029.
6. Li Q, Lu Q, Hwang JY, et al. (1999) IKK1-deficient mice exhibit abnormal development of skin and skeleton. Genes Dev 13: 1322-1328.
7. Takeda K, Takeuchi O, Tsujimura T, Itami S, Adachi O, et al. (1999) Limb and skin abnormalities in mice lacking IKKalpha. Science 284: 313-316.
8. Hu Y, Baud V, Delhase M, Zhang P, Deerinck T, et al. (1999) Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase. Science 284: 316-320.
9. Hu Y, Baud V, Oga T, Kim KI, Yoshida K, et al. (2001) IKKalpha controls formation of the epidermis independently of NF-kappaB. Nature 410: 710-714.
10. Sil AK, Maeda S, Sano Y, Roop DR, Karin M, (2004) IkappaB kinase-alpha acts in the epidermis to control skeletal and craniofacial morphogenesis. Nature 428: 660-664.
11. Gareus R, Huth M, Breiden B, Nenci A, Rosch N, et al. (2007) Normal epidermal differentiation but impaired skin-barrier formation upon keratinocyte-restricted IKK1 ablation. Nat Cell Biol 9: 461-469.
12. Liu B, Xia X, Zhu F, Park E, Carbajal S, et al. (2008) IKKalpha is required to maintain skin homeostasis and prevent skin cancer. Cancer Cell 14: 212-225.
13. Park E, Zhu F, Liu B, Xia X, Shen J, et al. (2007) Reduction in IkappaB kinase alpha expression promotes the development of skin papillomas and carcinomas. Cancer Res 67: 9158-9168.
14. Merkhofer EC, Cogswell P, Baldwin AS, (2010) Her2 activates NF-kappaB and induces invasion through the canonical pathway involving IKKalpha. Oncogene 29: 1238-1248.
15. Jiang R, Xia Y, Li J, Deng L, Zhao L, et al. (2010) High expression levels of IKKalpha and IKKbeta are necessary for the malignant properties of liver cancer. Int J Cancer 126: 1263-1274.
16. Mahato R, Qin B, Cheng K, (2010) Blocking IKKalpha Expression Inhibits Prostate Cancer Invasiveness. Pharm Res; Epub ahead of print.
17. Luo JL, Tan W, Ricono JM, Korchynskyi O, Zhang M, et al. (2007) Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin. Nature 446: 690-694.
18. Charalambous MP, Lightfoot T, Speirs V, Horgan K, Gooderham NJ, (2009) Expression of COX-2, NF-kappaB-p65, NF-kappaB-p50 and IKKalpha in malignant and adjacent normal human colorectal tissue. Br J Cancer 101: 106-115.
19. Fernandez-Majada V, Aguilera C, Villanueva A, Vilardell F, Robert-Moreno A, et al. (2007) Nuclear IKK activity leads to dysregulated notch-dependent gene expression in colorectal cancer. Proc Natl Acad Sci U S A 104: 276-281.
20. Bailey CM, Khalkhali-Ellis Z, Seftor EA, Hendrix MJ, (2006) Biological functions of maspin. J Cell Physiol 209: 617-624.
21. Khalkhali-Ellis Z, (2006) Maspin: the new frontier. Clin Cancer Res 12: 7279-7283.
22. Shi HY, Zhang W, Liang R, Abraham S, Kittrell FS, et al. (2001) Blocking tumor growth, invasion, and metastasis by maspin in a syngeneic breast cancer model. Cancer Res 61: 6945-6951.
23. Futscher BW, O'Meara MM, Kim CJ, Rennels MA, Lu D, et al. (2004) Aberrant methylation of the maspin promoter is an early event in human breast cancer. Neoplasia 6: 380-389.
24. Abraham S, Zhang W, Greenberg N, Zhang M, (2003) Maspin functions as tumor suppressor by increasing cell adhesion to extracellular matrix in prostate tumor cells. J Urol 69: 1157-1161.
25. Zhang M, Volpert O, Shi YH, Bouck N, (2000) Maspin is an angiogenesis inhibitor. Nat Med 6: 196-199.
26. Boltze C, (2005) Loss of maspin is a helpful prognosticator in colorectal cancer: a tissue microarray analysis. Pathol Res Pract 200: 783-790.
27. Yoshizawa K, Nozaki S, Okamune A, Rennels MA, Lu D, et al. (2009) Loss of maspin is a negative prognostic factor for invasion and metastasis in oral squamous cell carcinoma. J Oral Pathol Med 38: 535-539.
28. Zheng HC, Saito H, Masuda S, Wang ZG, Takano Y, (2008) Cytoplasmic and nuclear maspin expression in lung carcinomas: an immunohistochemical study using tissue microarrays. Appl Immunohistochem Mol Morphol 16: 459-465.
29. Marioni G, Blandamura S, Giacomelli L, Calgaro N, Segato P, et al. (2005) Nuclear expression of maspin is associated with a lower recurrence rate and a longer disease-free interval after surgery for squamous cell carcinoma of the larynx. Histopathology 46: 576-582.
30. Chua R, Setzer S, Govindarajan B, Sexton D, Cohen C, et al. (2009) Maspin expression, angiogenesis, prognostic parameters, and outcome in malignant melanoma. J Am Acad Dermatol 60: 758-766.
31. O'Donnell JD, Linger RJ, Kruk PA, (2010) BRCA1 185delAG mutant protein, BRAt, up-regulates maspin in ovarian epithelial cells. Gynecol Oncol 116: 262-268.
32. Cao D, Zhang Q, Wu LS, Salaria SN, Winter JW, et al. (2007) Prognostic significance of maspin in pancreatic ductal adenocarcinoma: tissue microarray analysis of 223 surgically resected cases. Mod Pathol 20: 570-578.
33. Dietmaier W, Bettstetter M, Wild PJ, Woenckhaus M, Rummele P, et al. (2006) Nuclear Maspin expression is associated with response to adjuvant 5-fluorouracil based chemotherapy in patients with stage III colon cancer. Int J Cancer 118: 2247-2254.
34. Stark AM, Schem C, Maass N, Hugo HH, Jonat W, et al. (2010) Expression of metastasis suppressor gene maspin is reduced in breast cancer brain metastases and correlates with the estrogen receptor status. Neurol Res 32: 303-308.
35. Karin M, (2008) The IkappaB kinase- a bridge between inflammation and cancer. Cell Res 18: 334-342.
36. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, et al. (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117: 927-939.
37. Puisieux A, Valsesia-Wittmann S, Ansieau S, (2006) A twist for survival and cancer progression. Br J Cancer 94: 13-17.
38. Ansieau S, Bastid J, Doreau A, Morel AP, Bouchet BP, et al. (2008) Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell 14: 79-89.
39. Owens DM, Romero MR, Gardner C, Watt FM, (2003) Suprabasal alpha6beta4 integrin expression in epidermis results in enhanced tumourigenesis and disruption of TGFbeta signalling. J Cell Sci 116: 3783-3791.
40. Tennenbaum T, Weiner AK, Belanger AJ, Glick AB, Hennings H, et al. (1993) The suprabasal expression of alpha 6 beta 4 integrin is associated with a high risk for malignant progression in mouse skin carcinogenesis. Cancer Res 53: 4803-4810.
41. Alameda JP, Moreno-Maldonado R, Navarro M, Bravo A, Ramirez A, et al. (2010) An inactivating CYLD mutation promotes skin tumor progression by conferring enhanced proliferative, survival and angiogenic properties to epidermal cancer cells. Oncogene 29: 6522-6532.
42. Leder A, Kuo A, Cardiff RD, Sinn E, Leder P, (1990) v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: effects of phorbol esters and retinoic acid. Proc Natl Acad Sci U S A 87: 9178-9182.
43. Ramirez A, Bravo A, Jorcano JL, Vidal M, (1994) Sequences 5′ of the bovine keratin 5 gene direct tissue- and cell-type-specific expression of a lacZ gene in the adult and during development. Differentiation 58: 53-64.
44. Casanova ML, Larcher F, Casanova B, Murillas R, Fernandez-Acenero MJ, et al. (2002) A critical role for ras-mediated, epidermal growth factor receptor-dependent angiogenesis in mouse skin carcinogenesis. Cancer Res 62: 3402-3407.
45. Jost M, Kari C, Rodeck U, (2000) The EGF receptor- an essential regulator of multiple epidermal functions. Eur J Dermatol 10: 505-510.
46. Rikimaru K, Moles JP, Watt FM, (1997) Correlation between hyperproliferation and suprabasal integrin expression in human epidermis reconstituted in culture. Exp Dermatol 6: 214-221.
47. Balmain A, Pragnell IB, (1983) Mouse skin carcinomas induced in vivo by chemical carcinogens have a transforming Harvey-ras oncogene. Nature 303: 72-74.
48. Casanova ML, Bravo A, Martinez-Palacio J, Fernandez-Acenero MJ, Villanueva C, et al. (2004) Epidermal abnormalities and increased malignancy of skin tumors in human epidermal keratin 8-expressing transgenic mice. Faseb J 18: 1556-1558.
49. Winter H, Rentrop M, Nischt R, Schweizer J, (1990) Tissue-specific expression of murine keratin K13 in internal stratified squamous epithelia and its aberrant expression during two-stage mouse skin carcinogenesis is associated with the methylation state of a distinct CpG site in the remote 5′-flanking region of the gene. Differentiation 43: 105-114.
50. Marinari B, Moretti F, Botti E, Giustizieri ML, Descargues P, et al. (2008) The tumor suppressor activity of IKKalpha in stratified epithelia is exerted in part via the TGF-beta antiproliferative pathway. Proc Natl Acad Sci U S A 105: 17091-17096.
51. Albanese C, Wu K, D'Amico M, Jarrett C, Joyce D, et al. (2003) IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf. Mol Biol Cell 14: 585-599.
52. Ohuchida K, Mizumoto K, Ohhashi S, Yamaguchi H, Konomi H, et al. (2007) Twist, a novel oncogene, is upregulated in pancreatic cancer: clinical implication of Twist expression in pancreatic juice. Int J Cancer 120: 1634-1640.
53. Lee TK, Poon RT, Yuen AP, Ling MT, Kwok WK, et al. (2006) Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin Cancer Res 12: 5369-5376.
54. Zhang Z, Xie D, Li X, Wong YC, Xin D, et al. (2007) Significance of TWIST expression and its association with E-cadherin in bladder cancer. Hum Pathol 38: 598-606.
55. Lamberti C, Lin KM, Yamamoto Y, Verma U, Verma IM, et al. (2001) Regulation of beta-catenin function by the IkappaB kinases. J Biol Chem 276: 42276-42286.
56. Park KJ, Krishnan V, O'Malley BW, Yamamoto Y, Gaynor RB, (2005) Formation of an IKKalpha-dependent transcription complex is required for estrogen receptor-mediated gene activation. Mol Cell 18: 71-82.
57. Wu RC, Qin J, Hashimoto Y, Wong J, Xu J, et al. (2002) Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) Coactivator activity by I kappa B kinase. Mol Cell Biol 22: 3549-3561.
58. Yamamoto Y, Verma UN, Prajapati S, Kwak YT, Gaynor RB, (2003) Histone H3 phosphorylation by IKK-alpha is critical for cytokine-induced gene expression. Nature 423: 655-659.
59. Anest V, Hanson JL, Cogswell PC, Steinbrecher KA, Strahl BD, et al. (2003) A nucleosomal function for IkappaB kinase-alpha in NF-kappaB-dependent gene expression. Nature 423: 659-663.
60. Huang WC, Ju TK, Hung MC, Chen CC, (2007) Phosphorylation of CBP by IKKalpha promotes cell growth by switching the binding preference of CBP from p53 to NF-kappaB. Mol Cell 26: 75-87.
61. DeBusk LM, Massion PP, Lin PC, (2008) IkappaB kinase-alpha regulates endothelial cell motility and tumor angiogenesis. Cancer Res 68: 10223-10228.
62. Brown K, Strathdee D, Bryson S, Lambie W, Balmain A, (1998) The malignant capacity of skin tumours induced by expression of a mutant H-ras transgene depends on the cell type targeted. Curr Biol 8: 516-524.
63. Trimboli AJ, Cantemir-Stone CZ, Li F, Wallace JA, Merchant A, et al. (2009) Pten in stromal fibroblasts suppresses mammary epithelial tumours. Nature 461: 1084-1091.